
Aaron Drucker
@aaron_drucker
Dermatologist, Women's College Hospital & University of Toronto. Focusing on epidemiology and evidence-based treatment of skin disease.
ID: 4063414312
http://eczematherapies.com 28-10-2015 21:34:54
1,1K Tweet
1,1K Followers
388 Following


Great support to kickstart my career from Marathon of Hope Cancer Centres Network and Terry Fox Research Institute. Good news for patients with understudied yet most common skin cancers in Canada.

1/ Spotted this interesting study on the risk of cardiovascular (CV) outcomes in pemphigus on rituximab compared with azathioprine (AZA) and/or mycophenolate mofetil (MMF) in JAMA Dermatology How do we interpret these results in the light of strengths and limitations of this study?



Please our new #review by Anna Trier #atopicdermatitis #eczema #therapies #biologics #itch #JAK #treatments #neuroimmune - she also has another paper #underreview Journal of Allergy and Clinical Immunology on #Il33 #histamine #itch academic.oup.com/bjd/advance-ar…




Great post-doc opportunity alert---->Data and Derm! Aaron Drucker Please share and RT! #EpiTwitter #phdchat

Previous studies have not looked at the variations in the amount of topical steroids prescribed to #patients by #dermatologists & #physicians. Our new #study in JAAD Journals sought to estimate the differences ➡️ bit.ly/3mFyLPd Women's College Hospital


From Alexa Bowie, Mina T., @NoahIvers, Aaron Drucker: A comparison of family physician and dermatologist topical corticosteroid prescriptions: A population-based cross-sectional study pubmed.ncbi.nlm.nih.gov/36914480/

Family #physicians prescribe about 50% ⬇️ less volume of topical steroids than #dermatologists, our new #study in JAAD Journals found. This could impact treatment of a patient's skin condition. Read the research findings ➡️ bit.ly/3mFyLPd Women's College Hospital






Important announcement from John McGrath: John McGrath, Professor of Molecular Dermatology at St John’s Institute of Dermatology in London, has been appointed as our next editor-in-chief. Professor McGrath will serve as editor-elect for a year before taking over in July 2024!

